Lv3
295 积分 2021-08-13 加入
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer
7个月前
已完结
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
7个月前
已完结
Facts and hopes in immunotherapy for early-stage triple-negative breast cancer
7个月前
已完结
Strong Programmed Death Ligand 1 Expression Predicts Poor Response and De Novo Resistance to EGFR Tyrosine Kinase Inhibitors Among NSCLC Patients With EGFR Mutation
1年前
已完结
Pathogenesis, diagnosis and treatment of paraneoplastic neurologic syndromes
1年前
已完结
Neoadjuvant immunotherapy in patients with pulmonary lymphoepithelioma-like carcinoma
1年前
已完结
Therapeutic revolution for inoperable stage III non-small cell lung cancer in the immune era
1年前
已完结
Insulin resistance in first-trimester pregnant women with pre-pregnant glucose tolerance and history of recurrent spontaneous abortion
1年前
已关闭
Genomic and expressional dynamics of ovarian cancer cell lines in PARPi treatment revealed mechanisms of acquired resistance
1年前
已完结
Long noncoding RNA NEAT1 promotes the growth of cervical cancer cells via sponging miR-9-5p
1年前
已完结
皖公网安备34019202002308
